British Journal of Cancer publishes first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK.
British Journal of Cancer publishes NET Patient Foundation’s research into impact of neuroendocrine morphology on cancer outcome and stage at diagnosis NET Patient Foundation in collaboration with Public Health England have undertaken the first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK to identify areas of unmet need with an aim to inform service improvement.
Recent News
UK Government announces commitment to a National Cancer Strategy for England
UK Government announces commitment to a National Cancer Strategy for England Several weeks ago, Neuroendocrine Cancer UK, and fellow charities, co-signed the joint One Cancer Voice letter to the Secretary of State for Health and Social Care, Wes Streeting,...
Neuroendocrine Cancer Headlining the News
OCTOBER 2024 19/10//2024 'Doctors put my symptoms down to allergy - now I've got incurable cancer' It took four years for a cancer sufferer to get treatment for his very rare disease and by the time he did it had become incurable and inoperable. Saying he was going to...
PERT Update
As some of you may be aware, we are working with fellow charities and patient organisations to ‘lobby’ and work with the government and other stakeholders to better address PERT shortages. Our working group of charities and patient organisations meets monthly, and...